Buprenorphine is available under several brand names, with Suboxone being one of the most recognized. Suboxone is a combination medication containing buprenorphine and naloxone, prescribed for the treatment of opioid use disorder [1]. Buprenorphine itself is an opioid partial agonist, meaning it binds to opioid receptors but with a lower intensity of effect than full agonists, which can help reduce cravings and withdrawal symptoms [2].
What is buprenorphine used for?
Buprenorphine is primarily used to manage opioid use disorder (OUD). It is part of medication-assisted treatment (MAT) programs, which combine medications with counseling and behavioral therapies to treat addiction [3]. It can also be used for pain management in certain situations [2].
What are the different brand names for buprenorphine products?
In addition to Suboxone, other brand names for buprenorphine-containing medications include Subutex, Belbuca, Buprenex, and Cassipa [4, 5]. Subutex contains only buprenorphine and was historically used for OUD and pain before naloxone was added to combination products [5]. Belbuca is a film that dissolves in the mouth and is used for chronic pain [6]. Buprenex is an injectable form used for moderate to severe pain [7]. Cassipa is a combination of buprenorphine and naloxone available as a film [5].
How does Suboxone work?
Suboxone contains buprenorphine, which blocks the effects of opioids like heroin or prescription painkillers, and naloxone. Naloxone is an opioid antagonist that is included to deter misuse of the medication. If Suboxone is injected, the naloxone can trigger withdrawal symptoms [1].
When do patents for buprenorphine products expire?
The patent landscape for buprenorphine products is complex and evolves with new formulations and combinations. Information on specific patent expiry dates for various buprenorphine products can be found through resources like DrugPatentWatch.com [8]. Generally, patent protection aims to provide a period of market exclusivity for the innovator drug, after which generic versions may become available.
Can generic versions of buprenorphine be made?
Yes, generic versions of buprenorphine and buprenorphine/naloxone combination products can be developed and marketed once the relevant patents and exclusivity periods have expired [8]. The availability of generics can lead to lower treatment costs [9].
What are the side effects of buprenorphine?
Common side effects of buprenorphine products can include headache, nausea, vomiting, sweating, dizziness, drowsiness, and constipation [1]. More serious side effects can occur, and patients should discuss these with their healthcare provider [1, 2].
How is buprenorphine administered?
Buprenorphine is available in various forms, including sublingual films (dissolved under the tongue), tablets that dissolve under the tongue, injections, and buccal films [5, 6, 7]. The method of administration depends on the specific product and the condition being treated.
Sources:
1. https://www.suboxone.com/
2. https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/what-are-different-types-medications-to-treat-opioid-addiction
3. https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine
4. https://www.ncbi.nlm.nih.gov/books/NBK548111/
5. https://www.goodrx.com/buprenorphine/drug-names
6. https://www.belbuca.com/
7. https://www.drugs.com/pro/buprenorphine-injection.html
8. https://drugpatentwatch.com/
9. https://www.hhs.gov/opioids/treatment/medications-for-opioid-use-disorder/index.html